KP405 clinical trials

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

This early study is looking at a new medicine called KP405 for Parkinson's disease. We want to see if it's safe for people with and without Parkinson's, how their bodies handle it, and if it has any effects. It's a first step to see if it could help in the future.